Share Us: Subscribe | Contact

Biblio

Export 3289 results:

Tagged

Author Title Type [ Year

]

2017

A. T. van der Ven, Pape, J. C., Hermann, D., Schloesser, R., Genius, J., Fischer, N., Mößner, R., Scherbaum, N., Wiltfang, J., Rujescu, D., and Benninghoff, J., “Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 2, pp. 531-540, 2017.

A. Stoccoro, Tannorella, P., Salluzzo, M. Grazia, Ferri, R., Romano, C., Nacmias, B., Siciliano, G., Migliore, L., and Coppedè, F., “The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1451-1457, 2017.

A. Cagnin, Mariotto, S., Fiorini, M., Gaule, M., Bonetto, N., Tagliapietra, M., Buratti, E., Zanusso, G., Ferrari, S., and Monaco, S., “Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy.”, J Alzheimers Dis, vol. 59, no. 1, pp. 13-20, 2017.

J. Riancho, Vázquez-Higuera, J. Luis, Pozueta, A., Lage, C., Kazimierczak, M., Bravo, M., Calero, M., Gonalezález, A., Rodríguez, E., Lleo, A., and Sánchez-Juan, P., “MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.”, J Alzheimers Dis, vol. 57, no. 2, pp. 483-491, 2017.

T. A. Lusardi, Phillips, J. I., Wiedrick, J. T., Harrington, C. A., Lind, B., Lapidus, J. A., Quinn, J. F., and Saugstad, J. A., “MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1223-1233, 2017.

R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G., “Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”, J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.

Z. Ismail, Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., and Lyketsos, C., “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.

J. A. Amorim, Canas, P. M., Tomé, A. R., Rolo, A. P., Agostinho, P., Palmeira, C. M., and Cunha, R. A., “Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 525-536, 2017.

H. P Reddy, Manczak, M., and Yin, X. L., “Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 147-162, 2017.

I. V. A. Martins, Rivers-Auty, J., Allan, S. M., and Lawrence, C. B., “Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 915-932, 2017.

Q. Cai and Tammineni, P., “Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1087-1103, 2017.

H. M. Wilkins, Mahnken, J. D., Welch, P., Bothwell, R., Koppel, S., Jackson, R. L., Burns, J. M., and Swerdlow, R. H., “A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.”, J Alzheimers Dis, vol. 59, no. 1, pp. 291-300, 2017.

L. Guo, Tian, J., and Du, H., “Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1071-1086, 2017.

Q. Yu, Du, F., Douglas, J. T., Yu, H., Yan, S. ShiDu, and Yan, S. Fang, “Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 59, no. 1, pp. 223-239, 2017.

H. Wang, Hong, X., and Wang, Y., “Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.”, J Alzheimers Dis, vol. 56, no. 3, pp. 875-883, 2017.

E. Wawrziczny, Berna, G., Ducharme, F., Kergoat, M. - J., Pasquier, F., and Antoine, P., “Modeling the Distress of Spousal Caregivers of People with Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 703-716, 2017.

M. L. Alosco, Duskin, J., Besser, L. M., Martin, B., Chaisson, C. E., Gunstad, J., Kowall, N. W., McKee, A. C., Stern, R. A., and Tripodis, Y., “Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.”, J Alzheimers Dis, vol. 57, no. 3, pp. 953-968, 2017.

R. J. Dougherty, Schultz, S. A., Kirby, T. K., Boots, E. A., Oh, J. M., Edwards, D., Gallagher, C. L., Carlsson, C. M., Bendlin, B. B., Asthana, S., Sager, M. A., Hermann, B. P., Christian, B. T., Johnson, S. C., Cook, D. B., and Okonkwo, O. C., “Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1089-1097, 2017.

S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S., “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.

N. - M. Suhonen, Hallikainen, I., Hänninen, T., Jokelainen, J., Krüger, J., Hall, A., Pikkarainen, M., Soininen, H., and Remes, A. M., “The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1241-1251, 2017.

Y. Huang, Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W. - X., and Zhang, Y. - X., “Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 885-897, 2017.

X. - J. Liu, Wei, J., Shang, Y. - H., Huang, H. - C., and Lao, F. - X., “Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1157-1170, 2017.

A. Saul Costa, Agostini, S., Guerini, F. Rosa, Mancuso, R., Zanzottera, M., Ripamonti, E., Racca, V., Nemni, R., and Clerici, M., “Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1055-1063, 2017.

M. B. Evgen'ev, Krasnov, G. S., Nesterova, I. V., Garbuz, D. G., Karpov, V. L., Morozov, A. V., Snezhkina, A. V., Samokhin, A. N., Sergeev, A., Kulikov, A. M., and Bobkova, N. V., “Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1415-1426, 2017.

E. Borland, Nägga, K., Nilsson, P. M., Minthon, L., Nilsson, E. D., and Palmqvist, S., “The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.”, J Alzheimers Dis, vol. 59, no. 3, pp. 893-901, 2017.

Pages